Cantourage

Cantourage is a leading European medical cannabis company headquartered in Berlin, Germany. The company operates a vertically integrated business model that includes the import, processing, and distribution of cannabis-based medicinal products. Through its proprietary "Fast Track Access" platform, Cantourage enables international cultivators to navigate the complex European regulatory landscape and bring their products to market efficiently. Their product portfolio encompasses dried flowers, medical extracts, and Dronabinol, serving a wide range of therapeutic areas such as chronic pain and oncology. Cantourage is publicly traded on the Frankfurt Stock Exchange and remains focused on expanding its footprint across the European healthcare sector.